Therefore, the upregulation of IL-6 during obesity may represent an adaptive mechanism aimed at enhancing insulin production and ameliorating glucose tolerance to counteract obesity-related insulin resistance. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.